GeneDx Holdings (WGS) FCF Margin (2020 - 2026)

GeneDx Holdings (WGS) has reported FCF Margin for 7 consecutive years, with 34.16% the latest figure, recorded in Q2 2026.

• On a quarterly basis, FCF Margin fell 4200.0% year-over-year to 34.16% in Q2 2026; TTM through Jun 2026 was 16.68%, a 1691.0% decrease from a year earlier, with the FY2025 full-year figure at 3.34%, up 1446.0% from the prior year.
• FCF Margin was 34.16% for Q2 2026 at GeneDx Holdings, up from 38.0% in the prior quarter.
• Over five years, FCF Margin peaked at 8.22% in Q3 2025 and troughed at 239.34% in Q2 2022.
• A 5-year average of 60.81% and a median of 36.08% in 2026 frame the typical range for FCF Margin.
• Across the five-year window, FCF Margin slumped 17865 bps in 2022 and soared 12603 bps in 2023, its largest moves.
• Over 5 years, FCF Margin stood at 106.48% in 2022, then soared by 47 bps to 56.14% in 2023, then soared by 89 bps to 6.34% in 2024, then rose by 3 bps to 6.15% in 2025, then sank by 456 bps to 34.16% in 2026.
• The last three FCF Margin figures came in at 34.16% (Q2 2026), 38.0% (Q1 2026), and 6.15% (Q4 2025), per Business Quant data.